Annovis Bio, Inc.

NYSE:ANVS

Biotechnology

Healthcare
$1.21 +0.00%

+$0.00 today

Market cap
$51.64M
Beta
1.24
P/E (TTM)
-1.1
EPS (TTM)
-$1.47
52W Low $1.54High $5.50

Volume 1.35M

Average 1.08M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$29.70M

FY 2025 · Annual

Net Income

-$28.85M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development8.48M16.52M38.79M20M25.22M
Selling, General & Admin6.06M9M6.24M6.7M4.48M
Operating Expenses14.54M25.51M45.04M26.69M29.7M
Depreciation & Amortization00000
EBITDA(14.5M)(25.33M)(56.2M)(22.74M)(28.85M)
EBITDA Margin—————
Operating Income(14.54M)(25.51M)(45.04M)(26.69M)(29.7M)
Operating Margin—————
Interest Income13.34K182.71K667.9K331.85K699.06K
Interest Expense0001.85M0
Other Income / Expenses50.09K182.71K(11.17M)2.1M841.06K
Income Before Tax(14.49M)(25.33M)(56.2M)(24.59M)(28.85M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(14.49M)(25.33M)(56.2M)(24.59M)(28.85M)
Net Margin—————
EPS (Basic)(1.90)(3.10)(6.23)(2,018.50)(1.40)
EPS (Diluted)(1.90)(3.10)(6.23)(2,009.77)(1.40)
Weighted Avg Shares7.63M8.16M9.02M12.18M20.55M
Weighted Avg Shares (Diluted)7.63M8.16M9.02M12.24M20.55M

ANVS Earnings Waterfall · TTM

NYSE:ANVS · Revenue to Net Income

Key Ratios

EPS$-1.72
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.5
P/S Ratio0.0

Analysis

$0 of revenue converted into -$40.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.72, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEF 14ADEF 14A filingSep 11, 2026
PRE 14APRE 14A filingAug 25, 2026
10-QQuarterly reportAug 14, 2026
SC 13GSC 13G filingAug 14, 2026
8-KCurrent reportAug 14, 2026

How much revenue does ANVS generate?

Annovis Bio, Inc. (ANVS) reported $0.00 of revenue in fiscal 2025.

Is ANVS profitable?

Annovis Bio, Inc. (ANVS) reported -$28.85M of net income.